SEC Form 4 research
| Issuer | Lyell Immunopharma, Inc. |
|---|---|
| Tickers | LYEL |
| Reporting owners | 38 |
| Officers and directors | 12 |
| Last public filing | 2026-11-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-05 | 2026-11-04 | ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX, LLC | P | 2,321,262 | $10.77 | Not reported |
| 2026-11-05 | 2026-11-04 | ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, BERNS PAUL L, BYBEE CLINTON, Burow Kristina, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT | P | 2,321,262 | $10.77 | Not reported |
| 2026-10-13 | 2026-10-12 | Aguirre Jarrad Mattieu | S | 422 | $8.63 | Not reported |
| 2026-09-10 | 2026-09-10 | Shook David | S | 500 | $12.7 | Not reported |
| 2026-09-10 | 2026-09-10 | Aguirre Jarrad Mattieu | A | 47,500 | $0 | Not reported |
| 2026-08-25 | 2026-08-21 | Lee Gary K. | S | 1,457 | $15.54 | Not reported |
| 2026-08-25 | 2026-08-21 | Hill Stephen J. | S | 989 | $15.54 | Not reported |
| 2026-08-25 | 2026-08-21 | Seely Lynn | S | 9,589 | $15.54 | Not reported |
| 2026-08-11 | 2026-08-10 | Bulis Veronica Sanchez | S | 621 | $14.34 | Not reported |
| 2026-08-11 | 2026-08-10 | Lee Gary K. | S | 131 | $14.34 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.